Does Pneumococcal Vaccination Have an Effect on Hospital Costs?
Journal
Thoracic research and practice
ISSN: 2979-9139
Titre abrégé: Thorac Res Pract
Pays: Turkey
ID NLM: 9918609982606676
Informations de publication
Date de publication:
May 2023
May 2023
Historique:
medline:
28
7
2023
pubmed:
28
7
2023
entrez:
28
7
2023
Statut:
ppublish
Résumé
It is known that inpatient hospital costs are much higher than outpatient services. It was aimed to investigate the effect of pneumococcal vaccination on hospitalizations. The direct hospitalization costs, length of stay, and factors of the vaccinated and unvaccinated patients in the same hospital during the 12-month follow-up of the patients who received pneumococcal vaccine between November 15, 2018, and November 15, 2020, in 3 chest diseases and thoracic surgery training and research hospitals were analyzed by obtaining Hospital Information Management System records. Data were collected with Statistical Package for the Social Sciences version 23 program (IBM Corp.; Armonk, NY, USA) , and statistical evaluation was made. The mean age of 800 hospitalized patients, of whom 400 were unvaccinated and 400 were vaccinated, was 68.48 ± 11.97. There was no significant difference in the mean age of vaccinated and unvaccinated patients (P > .05). Five hundred sixty-six patients (70.8%) were aged 65 and over. Two hundred eighty (51.2%) of men were vaccinated and 120 (47.2%) of women were vaccinated, and there was no significant difference (P > .05). The mean hospital stay of these patients was 11.01 days, and those in the vaccinated group had an average mean hospital stay of 9.11 days and those in the unvaccinated group had a mean hospital stay less than 12.91 days (P < .001). Total 1-year hospitalization costs were $501.653.53 and the cost per person was calculated as $627.07. The cost per capita for the vaccinated group was $550.52, which was lower than the average cost of the unvaccinated group ($703.62) (P < .05). When comparing the status of being vaccinated, comorbidity, mortality, mean length of stay, chronic obstructive pulmonary disease, and heart disease were found to be statistically significant (P < .05). In our study, it was revealed that vaccination of patients hospitalized in chest disease hospitals with the pneumococcal vaccine reduced the average length of hospital stay by 41.7% and the cost of hospitalization by 27.8%.
Identifiants
pubmed: 37503619
doi: 10.5152/ThoracResPract.2023.22171
pmc: PMC10346092
doi:
Types de publication
Journal Article
Langues
eng
Pagination
165-169Références
Tuberk Toraks. 2020 Sep;68(3):305-320
pubmed: 33295729
Eur Respir J. 2001 Jul;18(1):151-6
pubmed: 11510787
Am J Med. 2004 Aug 2;117 Suppl 3A:39S-50S
pubmed: 15360096
Clin Microbiol Infect. 2012 Oct;18 Suppl 5:7-14
pubmed: 22882668
Thorax. 1996 Oct;51(10):1010-6
pubmed: 8977602
Intern Med. 2001 Aug;40(8):703-7
pubmed: 11518106
Clin Respir J. 2014 Jan;8(1):93-9
pubmed: 23889911
Eur Respir J. 2006 Aug;28(2):346-51
pubmed: 16611653
Pharmacoeconomics. 2004;22(7):413-20
pubmed: 15137880
Hum Vaccin Immunother. 2017 Jul 3;13(7):1673-1680
pubmed: 28281915
Tuberk Toraks. 2007;55(2):191-212
pubmed: 17602349
Minerva Anestesiol. 2011 Feb;77(2):196-211
pubmed: 21242952
Int J Chron Obstruct Pulmon Dis. 2016 Mar 02;11:455-65
pubmed: 27042038
Chest. 2005 Oct;128(4):2238-46
pubmed: 16236880
BMC Health Serv Res. 2012 Oct 31;12:379
pubmed: 23113880
Bull World Health Organ. 2008 Feb;86(2):140-6
pubmed: 18297169
Am J Med. 2005 Jul;118 Suppl 7A:29S-38S
pubmed: 15993675
Patient. 2013;6(2):125-34
pubmed: 23549929
Expert Rev Vaccines. 2016;15(3):279-93
pubmed: 26651847
Am J Med. 2003 Oct 1;115(5):343-51
pubmed: 14553868
N Engl J Med. 2008 Nov 27;359(22):2355-65
pubmed: 19038881